1. Home
  2. ROIV vs AEE Comparison

ROIV vs AEE Comparison

Compare ROIV & AEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$38.91

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Logo Ameren Corporation

AEE

Ameren Corporation

N/A

Current Price

$112.40

Market Cap

31.2B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
ROIV
AEE
Founded
2014
1901
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
31.2B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ROIV
AEE
Price
$38.91
$112.40
Analyst Decision
Strong Buy
Buy
Analyst Count
13
19
Target Price
$50.82
★ $117.09
AVG Volume (30 Days)
★ 7.1M
1.6M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
★ 2.69%
EPS Growth
N/A
★ 21.04
EPS
N/A
★ 2.41
Revenue
$8,260,000.00
★ $8,799,000,000.00
Revenue This Year
$1,870.25
$8.41
Revenue Next Year
$271.46
$5.90
P/E Ratio
★ N/A
$46.29
Revenue Growth
N/A
★ 15.43
52 Week Low
$19.96
$96.57
52 Week High
$42.50
$118.32

Technical Indicators

Market Signals
Indicator
ROIV
AEE
Relative Strength Index (RSI) 54.07 57.14
Support Level $33.11 $108.69
Resistance Level $42.37 $112.67
Average True Range (ATR) 1.55 1.87
MACD -0.07 -0.38
Stochastic Oscillator 49.40 38.84

Price Performance

Historical Comparison
ROIV
AEE

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About AEE Ameren Corporation

Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas through the company's two main subsidiaries, Ameren Missouri and Ameren Illinois. It serves 2.5 million electricity customers and 900,000 natural gas customers across its two service territories.

Share on Social Networks: